| 英文名稱(chēng) |
中文名稱(chēng) |
CAS號(hào) |
操作 |
| Azithromycin Impurity J |
阿奇霉素雜質(zhì)J |
117693-41-1 |
詳細(xì)
|
| Prasugrel Impurity 7 |
普拉格雷雜質(zhì)7 |
1359829-72-3 |
詳細(xì)
|
| Ticagrelor Impurity M |
替格瑞洛雜質(zhì)M |
274693-39-9 |
詳細(xì)
|
| Tofacitinib Impurity 34 |
托法替尼雜質(zhì)34 |
1629858-78-1 |
詳細(xì)
|
| Azithromycin EP Impurity O |
阿奇霉素EP雜質(zhì)O |
763924-54-5 |
詳細(xì)
|
| Sildenafil Impurity 18 |
西地那非雜質(zhì)18 |
2196244-90-1 |
詳細(xì)
|
| Azithromycin Impurity M |
阿奇霉素雜質(zhì)M |
765927-71-7 |
詳細(xì)
|
| Tofacitinib Impurity D |
托法替尼雜質(zhì) D |
384338-23-2 |
詳細(xì)
|
| Terbutaline Impurity 21 |
特布他林雜質(zhì)21 |
28924-20-1 |
詳細(xì)
|
| DoxylaMine EP IMpurity B |
多西拉敏EP雜質(zhì)B |
19490-92-7 |
詳細(xì)
|
| Prasugrel-d5 |
普拉格雷雜質(zhì)5 |
1127252-92-9 |
詳細(xì)
|
| Tofacitinib Impurity 17 |
托法替尼雜質(zhì)17 |
2174011-55-1 |
詳細(xì)
|
| Avanafil Impurity 29 |
阿伐那非雜質(zhì)29 |
1364671-52-2 |
詳細(xì)
|
| Eltrombopag Impurity 1 |
艾曲波帕雜質(zhì)1 |
1437383-35-1 |
詳細(xì)
|
| Terbutaline Impurity 38 |
特布他林雜質(zhì)38 |
30923-82-1 |
詳細(xì)
|
| 2-Despiperidyl-2-amino Repaglinide |
2-去哌啶基-2-氨基瑞格列奈 |
637301-29-2 |
詳細(xì)
|
| Norfloxacin Impurity E |
環(huán)丙沙星雜質(zhì)E |
105394-83-0 |
詳細(xì)
|
| 5-Chloro-2-hydroxy-3-nitro-(1,1-biphenyl)-3-carboxylic acid |
5'-氯-3'-硝基-2'-羥基-[1,1'-聯(lián)苯]-3-甲酸 |
376592-58-4 |
詳細(xì)
|
| Avanafil Impurity N |
阿伐那非雜質(zhì)N |
330785-84-7 |
詳細(xì)
|
| Repaglinide IMpurity IV |
瑞格列奈雜質(zhì)IV |
646054-50-4 |
詳細(xì)
|
| Eltrombopag Impurity 6 |
艾曲波帕雜質(zhì)6 |
376592-56-2 |
詳細(xì)
|
| Lidocaine EP Impurity J |
利多卡因EP雜質(zhì)J |
1012864-23-1 |
詳細(xì)
|
| Repaglinide M1 Metabolite |
瑞格列奈 M1 代謝物 |
874908-11-9 |
詳細(xì)
|
| vildagliptin Impurity P |
維達(dá)列汀雜質(zhì)P |
1032564-18-3 |
詳細(xì)
|
| Ticagrelor Impurity N |
替格瑞洛雜質(zhì) |
1643378-47-5 |
詳細(xì)
|
| Avanafil Impurity 12 |
阿伐那非雜質(zhì)12 |
330786-34-0 |
詳細(xì)
|
| Terbutaline Impurity 3 |
特布他林雜質(zhì)3 |
1246815-70-2 |
詳細(xì)
|
| Azithromycin Impurity E |
阿奇霉素雜質(zhì)E |
612069-27-9 |
詳細(xì)
|
| Ciprofloxacin Impurity 21 |
環(huán)丙沙星雜質(zhì)21 |
105674-91-7 |
詳細(xì)
|
| Tofacitinib Impurity 15 |
托法替布雜質(zhì)15 |
1092578-48-7 |
詳細(xì)
|
| Prasugrel EP Impurity C |
普拉格雷 EP 雜質(zhì) C |
1391194-50-5 |
詳細(xì)
|
| R-DoxylaMine |
R-多西拉敏 |
1391849-33-4 |
詳細(xì)
|
| Ciprofloxacin Impurity 7 |
環(huán)丙沙星雜質(zhì)7 |
93594-29-7 |
詳細(xì)
|
| 1-[2,5-bis(benzyloxy)phenyl]ethan-1-one |
2,5-二芐氧基苯乙酮 |
21766-81-4 |
詳細(xì)
|
| Avanafil Impurity 15 |
阿伐那非雜質(zhì)15 |
2250242-48-7 |
詳細(xì)
|
| Lidocaine Impurity 19 |
利多卡因雜質(zhì) 19 |
1596965-85-3 |
詳細(xì)
|
| Vildagliptin Impurity 9 |
維達(dá)列汀雜質(zhì)9 |
2246354-69-6 |
詳細(xì)
|
| Ticagrelor Impurity 63 |
替卡格雷雜質(zhì)63 |
2227766-79-0 |
詳細(xì)
|
| 2-bromo-1-(3,5-dihydroxyphenyl)ethanone |
2-溴-3'.5'-二羥基苯乙酮 |
62932-92-7 |
詳細(xì)
|
| Sildenafil Impurity 66 |
西地那非雜質(zhì)66 |
253178-46-0 |
詳細(xì)
|
| Lidocaine Impurity 30 |
利多卡因雜質(zhì)30 |
39084-88-3 |
詳細(xì)
|
| Prasugrel Impurity M |
普拉格雷雜質(zhì)M |
1443034-67-0 |
詳細(xì)
|
| Avanafil Impurity H |
阿伐那非雜質(zhì)H |
1638497-26-3 |
詳細(xì)
|
| Prasugrel Impurity 4 |
普拉格雷雜質(zhì)4 |
1618107-96-2 |
詳細(xì)
|
| vildagliptin-d7 |
維格列汀-d7 |
1133208-42-0 |
詳細(xì)
|
| Terbutaline EP Impurity D |
特布他林 EP 雜質(zhì) D |
1797117-23-7 |
詳細(xì)
|
| Sildenafil Impurity 36 |
西地那非雜質(zhì)36 |
319491-68-4 |
詳細(xì)
|
| Sildenafil Impurity 37 |
西地那非雜質(zhì)37 |
1027192-92-2 |
詳細(xì)
|
| Ticagrelor Related Compound 94 HCl |
替卡格雷相關(guān)化合物94 HCl |
1643378-59-9 |
詳細(xì)
|
| Doxylamine Impurity 5 |
多西拉敏雜質(zhì)5 |
97143-65-2 |
詳細(xì)
|
| Sildenafil Impurity 67 |
西地那非雜質(zhì)67 |
358388-58-6 |
詳細(xì)
|
| Tofacitinib Impurity 13 |
托法替尼雜質(zhì)13 |
923036-30-0 |
詳細(xì)
|
| Prasugrel EP Impurity A |
普拉格雷 EP 雜質(zhì) A |
1391194-45-8 |
詳細(xì)
|
| vildagliptin Impurity 73 |
維達(dá)列汀雜質(zhì)73 |
1846606-32-3 |
詳細(xì)
|
| Carbazochrome Impurity |
卡絡(luò)磺鈉雜質(zhì) |
2271443-87-7 |
詳細(xì)
|
| Thiamine EP Impurity H |
硫胺素EP雜質(zhì)H |
89285-03-0 |
詳細(xì)
|
| Carboplatin Impurity 4 |
卡鉑雜質(zhì)4 |
113287-15-3 |
詳細(xì)
|
| 2-Despiperidyl-2-(5-carboxypentylamine) Repaglinide |
2-去哌啶基-2-(5-羧基戊胺)瑞格列奈 |
874908-12-0 |
詳細(xì)
|
| Ticagrelor InterMediate 1 |
替卡格雷中間體五元環(huán) |
274693-55-9 |
詳細(xì)
|
| Tofacitinib Impurity A |
托法替布雜質(zhì)A |
1092578-46-5 |
詳細(xì)
|
| Ticagrelor Impurity 2 |
替格瑞洛雜質(zhì)2 |
592533-90-9 |
詳細(xì)
|
| Ciprofloxacin Impurity 2 |
環(huán)丙沙星雜質(zhì)2 |
528851-30-1 |
詳細(xì)
|
| Doxylamine Impurity 7 |
多西拉敏雜質(zhì)7 |
105176-70-3 |
詳細(xì)
|
| Repaglinide Related CoMpound C |
瑞格列奈相關(guān)物質(zhì)C |
107362-12-9 |
詳細(xì)
|
| Terbutaline Impurity 27 |
特布他林雜質(zhì)27 |
147942-88-9 |
詳細(xì)
|
| Tofacitinib Impurity K |
托法替布雜質(zhì)K |
2328165-36-0 |
詳細(xì)
|
| Ticagrelor Impurity 81 |
替卡格雷雜質(zhì)81 |
2376278-68-9 |
詳細(xì)
|
| Lidocaine Impurity 27 |
利多卡因雜質(zhì) 27 |
112843-97-7 |
詳細(xì)
|
| Eltrombopag Impurity 10 |
艾曲波帕雜質(zhì)10 |
376592-93-7 |
詳細(xì)
|
| Lidocaine EP Impurity K |
利多卡因EP雜質(zhì)K |
50295-20-0 |
詳細(xì)
|
| Doxylamine d5 |
多西拉敏d5 |
1216840-94-6 |
詳細(xì)
|
| Azithromycin Impurity 18 |
阿奇霉素雜質(zhì)18 |
612069-31-5 |
詳細(xì)
|
| Lidocaine EP Impurity I |
利多卡因EP雜質(zhì)I |
17289-54-2 |
詳細(xì)
|
| Descarbon Sildenafil |
去乙烯基西地那非 |
466684-88-8 |
詳細(xì)
|
| Thiamine Impurity 10 |
鹽酸硫胺素雜質(zhì)10 |
855380-68-6 |
詳細(xì)
|
| Carbazochrome Sodium Sulfonate Impurity 1 |
卡絡(luò)磺鈉雜質(zhì)1 |
13383-73-8 |
詳細(xì)
|
| vildagliptin Impurity 57 |
維達(dá)列汀雜質(zhì)57 |
565452-98-4 |
詳細(xì)
|
| Eltrombopag Impurity 57 |
艾曲波帕雜質(zhì)57 |
893736-72-6 |
詳細(xì)
|
| 2-HYDROXY-3''-NITRO-BIPHENYL-3-CARBOXYLIC ACID |
2'-羥基-3'-硝基-[1,1'-聯(lián)苯]-3-羧酸 |
376591-95-6 |
詳細(xì)
|
| Prasugrel Impurity O |
普拉格雷雜質(zhì)O |
929211-64-3 |
詳細(xì)
|
| Azithromycin Impurity N |
阿奇霉素雜質(zhì)N |
612069-25-7 |
詳細(xì)
|
| Prasugrel EP Impurity B |
普拉格雷 EP 雜質(zhì) B |
1391194-39-0 |
詳細(xì)
|
| ErythroMycin A 9,11-IMino Ether |
紅霉素A 9,11-亞胺醚 |
161193-44-8 |
詳細(xì)
|
| Mutaprodenafil |
多丙地那非 |
1387577-30-1 |
詳細(xì)
|
| Norfloxacin EP Impurity F |
諾氟沙星EP雜質(zhì)F |
67681-84-9 |
詳細(xì)
|
| Carbazochrome sodium sulfonate iMpurit 6 |
卡絡(luò)磺鈉雜質(zhì)6 |
130570-60-4 |
詳細(xì)
|
| HydroxythiohoMo Sildenafil |
羥基硫代高西地那非 |
479073-82-0 |
詳細(xì)
|
| Repaglinide Impurity A |
瑞格列奈雜質(zhì)A |
220438-80-2 |
詳細(xì)
|
| Methyl 3,3-difluorocyclobutane-1-carboxylate |
3,3-二氟環(huán)丁烷甲酸甲酯 |
1234616-13-7 |
詳細(xì)
|
| 4-(3-chloro-4-MethoxybenzylaMino)-5-ethoxycarbonyl-2-MethylsulfinylpyriMidine |
阿伐那非中間體1 |
330785-82-5 |
詳細(xì)
|
| Ticagrelor Impurity 20 |
替格瑞洛雜質(zhì)20 |
376608-75-2 |
詳細(xì)
|
| Lidocaine Impurity E |
利多卡因雜質(zhì)E |
745798-07-6 |
詳細(xì)
|
| Vildagliptin Impurity C |
維格列汀雜質(zhì)C |
565453-41-0 |
詳細(xì)
|
| Lidocaine EP Impurity F |
利多卡因EP雜質(zhì)F |
857170-72-0 |
詳細(xì)
|
| Vildagliptin Related Compound D |
維格列汀相關(guān)化合物D |
565453-39-6 |
詳細(xì)
|
| Ciprofloxacin Impurity 9 |
環(huán)丙沙星雜質(zhì)9 |
1620445-09-1 |
詳細(xì)
|
| Vildagliptin Impurity 57 |
維格列汀雜質(zhì)57 |
913980-23-1 |
詳細(xì)
|
| Thiamine Impurity 11 |
鹽酸硫胺素雜質(zhì)11 |
855380-63-1 |
詳細(xì)
|
| Tofacitinib Impurity 42 |
托法替尼雜質(zhì)42 |
2504210-41-5 |
詳細(xì)
|
| (S)-Repaglinide Ethyl Ester (Repaglinide IMpurity) |
(S)-瑞格列奈乙基酯(瑞格列奈雜質(zhì)D） |
147770-06-7 |
詳細(xì)
|